Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2019 Sep 20;39(9):BSR20181853.
doi: 10.1042/BSR20181853. Print 2019 Sep 30.

Can a subgroup at high risk for LRR be identified from T1-2 breast cancer with negative lymph nodes after mastectomy? A meta-analysis

Affiliations
Meta-Analysis

Can a subgroup at high risk for LRR be identified from T1-2 breast cancer with negative lymph nodes after mastectomy? A meta-analysis

Gongling Peng et al. Biosci Rep. .

Abstract

Purpose: To identify a subgroup at high risk for loco-regional recurrence (LRR) from T1-2 breast cancer with negative lymph nodes (N0) after mastectomy by using a meta-analysis.Methods and materials: Published studies on the relationship between clinical features and LRR of breast cancer were identified from public databases, including PubMed, EMBASE, and the Cochrane Library. High-risk features for LRR in this patient population were defined based on the pooled results of meta-analysis.Results: For the meta-analysis, a total of 11244 breast cancers with pT1-2N0 after mastectomy from 20 publications were included for analysis. The pooled results indicated that age (hazard ratio (HR) 1.77, P=0.001), lymphovascular invasion (LVI) (HR 2.23, P<0.001), histologic grade (HR 1.66, P<0.001), HER2 status (HR 1.65, P=0.027), menopausal status (HR 1.36, P=0.015), and surgical margins (HR 2.56, P=0.014) were associated with a significantly increased risk of developing LRR in this patient population group, but not for tumor size (HR 1.32, P=0.23), systematic therapy (HR 1.67, P=0.20), and hormonal receptor status (HR 1.04, P=0.73).Conclusion: In the current study, patients with young age, positive LVI, high histologic grade, HER-2 positive, premenopausal, and positive surgical margins have an increased risk of developing LRR. Further prospective trials are needed to clearly define the role of adjuvant postmastectomy radiotherapy in T1-2N0 breast cancer at high risk of developing LRR.

Keywords: PMRT; breast cancer; local recurrence; risk factors.

PubMed Disclaimer

Conflict of interest statement

The authors declare that there are no competing interests associated with the manuscript.

Figures

Figure 1
Figure 1. PRISMA flow diagram
Figure 2
Figure 2. Meta-analysis of LRR rate in young versus elder patients
Figure 3
Figure 3. Meta-analysis of LRR rate in LVI versus no LVI
Figure 4
Figure 4. Meta-analysis of LRR rate in Grade III versus Grade I/II
Figure 5
Figure 5. Meta-analysis of LRR rate in HER2 positive versus HER2 negative

Similar articles

References

    1. Schoenfeld J.D. and Harris J.R. (2011) Abbreviated course of radiotherapy (RT) for breast cancer. Breast 20, S116–S127 10.1016/S0960-9776(11)70308-3 - DOI - PubMed
    1. Cheng S.H., Horng C.F., Clarke J.L.. et al. (2006) Prognostic index score and clinical prediction model of local regional recurrence after mastectomy in breast cancer patients. Int. J. Radiat. Oncol. Biol. Phys. 64, 1401–1409 10.1016/j.ijrobp.2005.11.015 - DOI - PubMed
    1. McGale P., Taylor C., Ebctcg et al. (2014) Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials. Lancet 383, 2127–2135 10.1016/S0140-6736(14)60488-8 - DOI - PMC - PubMed
    1. Buchanan C.L., Dorn P.L., Fey J.. et al. (2006) Locoregional recurrence after mastectomy: incidence and outcomes. J. Am. Coll. Surg. 203, 469–474 10.1016/j.jamcollsurg.2006.06.015 - DOI - PubMed
    1. Childs S.K., Chen Y.H., Duggan M.M.. et al. (2012) Surgical margins and the risk of local-regional recurrence after mastectomy without radiation therapy. Int. J. Radiat. Oncol. Biol. Phys. 84, 1133–1138 10.1016/j.ijrobp.2012.02.048 - DOI - PubMed

Publication types